About Allogene (ALLO)
Allogene Therapeutics, Inc. is a clinical stage immuno-oncology company. The Company is focused on developing and commercializing of allogeneic T cell therapies for the treatment of cancer. It is involved in developing a pipeline of multiple allogene... Read more
- USD1.19
- USD1.28
- USD1.15
- USD3.78
- -18.30%
- 0M
- 3.79M
- 3.03M
- 372M
- 1.09
- -59.40%
Stock News
5 hours ago
FAA weighs reducing Newark flights after hundreds of disruptions
CNBC
6 hours ago
Lutnick says 10% baseline tariff will stick around for "foreseeable future"
CNBC
6 hours ago
The ‘most important consumer earnings report of the season’ lands this week
MarketWatch
7 hours ago
People are feeling lousy about work. The internet's career advice expert has some tips
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
